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Beta cell injury due to oxidative stress is a typical eti-
ology of diabetes caused by nutritional excess, but
its precise mechanism remains largely elusive.
Here, we demonstrate that the microtubule motor
KIF12 mediates an antioxidant cascade in beta cells
as an intracellular target of excess fat intake or ‘‘lip-
otoxicity.’’ KIF12 knockout mice suffer from hypoin-
sulinemic glucose intolerance due to increased
beta cell oxidative stress. Using this model, we iden-
tified an antioxidant signaling cascade involving
KIF12 as a scaffold for the transcription factor
Sp1. The stabilization of nascent Sp1 appeared to
be essential for proper peroxisomal function by
enhancing Hsc70 expression, and the pharmacolog-
ical induction of Hsc70 expression with teprenone
counteracted the oxidative stress. Because KIF12
is transcriptionally downregulated by chronic expo-
sure to fatty acids, this antioxidant cascade involving
KIF12 and Hsc70 is proposed to be a critical target of
nutritional excess in beta cells in diabetes.
INTRODUCTION
Kinesin-superfamily proteins (KIFs) consist of an emerging
superfamily of molecular motors with functions largely related
to the microtubule cytoskeleton (Hirokawa et al., 2009). The
KIFs share a common motor domain that translocates along
microtubules and serve to convey cargos relevant to develop-
mental signaling (Nonaka et al., 1998; Teng et al., 2005; Ueno
et al., 2011; Zhou et al., 2009). Although the microtubule system
has been suggested to stabilize essential proteins in the cyto-
plasm (Ziegelbauer et al., 2001), whether and how microtubule
motors directly affect the stability of the cargo molecules have
not beenwell studied. KIF12 is an orphan kinesin-12 familymotor
protein identified by our degenerate PCR screening of a mouse
complementary DNA (cDNA) library (Nakagawa et al., 1997).
Pancreatic and kidney KIF12 expression is driven by hepatocyte
nuclear factor 1a/1b (HNF1a/1b) transcription factors and is
involved in the pathogenesis of polycystic kidney (Gong et al.,202 Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsev2009; Luco et al., 2008). However, the precise functional rele-
vance of KIF12 in pancreatic beta cells remains largely elusive.
Diabetes is one of the major lifestyle-mediated diseases, in
which excess nutritional intake destroys metabolic homeostasis
in humans (Ashcroft and Rorsman, 2012). In particular, chronic
intake of a high-fat diet (HFD) has been believed to increase
the risk of type 2 diabetes through the following two phases. In
the first phase, peripheral insulin resistance is increased by
obesity, which can initially be compensated for by the pancreatic
beta cells in the preclinical state. However, chronic excess nutri-
tional intake gradually increases beta cell dysfunction and finally
disrupts the glucose homeostasis to result in overt hyperglyce-
mia (Kasuga, 2006). Indeed, chronic exposure to excess fatty
acids (FAs) directly harms the beta cells via elevated oxidative
stress. This phenomenon is termed ‘‘beta cell lipotoxicity’’ (Lee
et al., 1994) and has potential as a therapeutic target against
the progression of diabetes (Oprescu et al., 2007; Schaffer,
2003). Because FAs significantly inactivate the transcription fac-
tors HNF1a/1b in beta cells (Johnstone et al., 2011; Ohtsubo
et al., 2011), it is believed that unknown downstream HNF1a/
1b target genes are involved in an essential antioxidant system
in beta cells and are responsible for lipotoxicity. In addition to lip-
otoxicity, glucose excess, termed glucotoxicity (Leahy, 1990), is
also an important cause of increased oxidative stress (Robertson
et al., 2004).
Heat shock cognate 70 (Hsc70), which is encoded by the
Hspa8 gene, is a constitutively expressed multifunctional molec-
ular chaperone of the heat shock protein 70 (Hsp70) family (Liu
et al., 2012) that confers oxidative protection (Chong et al.,
1998; Mosser et al., 2000; Robinson et al., 2008; Wang et al.,
2013). Hsc70 aids in the correct folding and stabilization of
nascent polypeptides as they emerge from the polyribosome
(Beckmann et al., 1990; Nelson et al., 1992). This protein is
also essential for the peroxisomal matrix targeting of antioxidant
enzymes such as catalase and glutathione peroxidase (GPx)
(Walton et al., 1994) via the function of peroxisomal import pro-
teins, including Pex5, that recognize the peroxisomal targeting
signals 1 and 2 (PTS1 and PTS2, respectively) (Subramani
et al., 2000). These properties of Hsc70 are considered to be
important for its antioxidant role, especially in beta cells, which
have low normal expression levels of antioxidant enzymes and
are largely vulnerable to oxidative stress (Lenzen et al., 1996).
Hsc70 expression is regulated by multiple steps, including
protein degradation (Wiederkehr et al., 2002), messenger RNAier Inc.
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Figure 1. KIF12 KO Mice Suffer from Beta Cell Dysfunction
(A) Full-length mouse Kif12 cDNA cloning. The predicted domain structure is presented. a.a., amino acids.
(B) Tissue distribution of KIF12 in indicated adult mouse tissues and MIN6 cells detected by immunoblotting with the 12PR anti-KIF12 antibody and the DM1A
anti-a-tubulin antibody.
(C) Characterization of a KIF12-KD system in MIN6 cells transduced with SC control or Kif12-KD miRNA vectors by immunoblotting with the 12T anti-KIF12
antibody.
(D) Gene-targeting strategy for the generation of Kif12-KO mice. Red and dark blue boxes represent the preserved and deleted Kif12 exons, respectively.
Genotyping PCR primers and genomic Southern strategy are included. bGeo/Puro, positive selection cassette; TK, negative selection cassette.
(E) Southern blot analyses of the homologous recombinant embryonic stem cell clone (Targeted) and a WT clone with the indicated strategies.
(F) Genotyping PCR using mouse tail DNA and the indicated primer sets.
(G) Immunoblotting of pancreatic islet lysates from Kif12+/+ (WT) and Kif12/ (KO) mice probed with the 12T anti-KIF12 antibody.
(legend continued on next page)
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KIF12 Regulates Oxidative Stress in Beta Cells(mRNA) degradation (Rubenstein and Lyons, 2001), and gene
transcription. The transcription ofHsc70 (Hspa8) gene is critically
modulated by several enhancer binding proteins, including Sp1,
NF-YA, and KLF4 (Lee et al., 2012; Liu et al., 2008; Marunouchi
and Hosoya, 1993; Wilke et al., 2000), and can be induced by
teprenone (geranylgeranylacetate, Selbex) (Hirakawa et al.,
1996), which is an antiulcer drug delivered to a wide range of
organs after oral administration (Nakada et al., 2005). Expression
of the transcription factor Sp1 is largely determined by the
cellular metabolic state (Han and Kudlow, 1997), which affects
the rate of Sp1 proteasomal degradation in the cytoplasm (Jia
et al., 2010; Mortensen et al., 1997). Hsc70 protein is essential
for protecting the transcription factor Sp1 from degradation in
prostate cancer cells (Li et al., 2013), suggesting the existence
of a positive feedback loop regulating Hsc70 gene expression.
However, the synergy between these antioxidant capacities
and oxidative stress in beta cells remains largely undetermined.
In this study, we established KIF12 knockout (KO) mice and
identified a molecular mechanism for beta cell lipotoxicity.
KIF12 KO beta cells were impaired in glucose-induced insulin
secretion (GSIS) and were characterized by elevated oxidative
stress due to the downregulation of Sp1, Hsc70, and peroxisome
biogenesis. Based on biochemistry and superresolution micro-
scopy, we provide cell biological evidence that KIF12 stabilizes
Sp1 by helping it form a complex with Hsc70 on microtubules
to augment Hsc70 transcription and peroxisome biogenesis,
reducing oxidative stress in beta cells. Interestingly, Kif12
expression was transcriptionally downregulated by FA treatment
in beta cells, suggesting that the KIF12 KO mouse serves as a
diabetes model of beta cell lipotoxicity. Finally, KIF12 or Hsc70
overexpression or teprenone treatment significantly reversed
the beta cell lipotoxicity. Thus, this antioxidant mechanism
involving KIF12 and Hsc70 will also be relevant as a therapeutic
target for preventing diabetes.
RESULTS
KO of KIF12 Disorganizes Mouse Glucose Homeostasis
To assess the physiological relevance and cellular function of
KIF12, we cloned and sequenced mouse full-length Kif12
cDNA (DNA Data Bank of Japan/EMBL/GenBank accession
number AB755406; Figure 1A; Figure S1A available online)
from 4-week-old mouse kidney. KIF12 is encoded by an open
reading frame comprising 648 amino acids containing a highly
conserved kinesin motor domain at the N terminus, a coiled-
coil stretch in the middle, and a proline-rich domain near the
C terminus (Figure 1A). Subsequently, we raised specific anti-
KIF12 polyclonal antibodies (Figure S1B). Immunoblotting of
adult tissues revealed a strong expression of KIF12 in the
pancreatic islets, the kidney, and the cultured mouse MIN6
pancreatic beta cell line (Miyazaki et al., 1990) (Figure 1B). The
specificity of the antibody was verified by microRNA (miRNA)-
mediated KIF12 knockdown (Figure 1C).(H and I) IPGTT in 3-month-old WT and KOmice indicating the time course of bloo
(H) and *p < 0.05; NS, p > 0.05 by Welch’s t test (I).
(J) GSIS in 30 min in WT and KO islets in the presence of the indicated concentr
(K) IPITT in 3-month-old WT (n = 4) and KO mice (n = 5). NS, p > 0.05 by two-wa
See also Figure S1.
204 Developmental Cell 31, 202–214, October 27, 2014 ª2014 ElsevTo investigate the phenotypes of KIF12 deficiency, we gener-
ated KIF12 KOmice by replacing the second to 11th exonswith a
positive selection cassette (Figures 1D–1G and Supplemental
Experimental Procedures). These KOmicewere viable and fertile
andexhibitedmild but significant glucose intolerance (Figure 1H).
This intolerance was considered to be primarily due to impair-
ment in GSIS from the pancreatic islets (Figures 1I and 1J)
because KIF12 expression in peripheral tissues was low (Fig-
ure 1B), and KIF12 deficiency largely did not alter insulin sensi-
tivity in an insulin tolerance test (Figure 1K). Thus, KIF12 may
play a role in beta cell dysfunction in diabetes.
Peroxisome Dysfunction May Mediate Oxidative Stress
Elevation in KIF12-KO Beta Cells
To investigate potential alterations in KIF12-KO beta cells, we
conducted a systemic cellular search for organelle abnormalities
using primary islet cells and MIN6 beta cells (Figures 2A and 2B;
Figure S2). Through this approach, we identified a specific defect
in peroxisome staining. Immunofluorescence for the PTS2
marker ACAA1 (Subramani et al., 2000) was significantly reduced
in KIF12 KO primary beta cells and in KIF12-KD MIN6 cells (Fig-
ure 2A). Furthermore, we generated an MIN6 cell line stably ex-
pressing enhanced cyan fluorescent protein (ECFP)-PTS1 driven
by the ubiquitous promoter pCMV to circumvent difficulties in
detecting PTS1-containing antioxidant enzymes in beta cells
(Lenzen et al., 1996) and to exclude any possible changes in its
promoter activity. As a result, KIF12 knockdown (KD) significantly
downregulated the ECFP signal compared with the scrambled
(SC) KD (Figure 2B). We also detected a significant downregula-
tion of Pex5 in KIF12-KD cells using immunoblotting, which was
restored by Kif12 cDNA transduction (Figure 2C).
The antioxidant capacities of catalase and GPx in KO islets
were significantly reduced compared with those in wild-type
(WT) islets (Figures 2D and 2E). The H2O2 levels in KO beta cells
were significantly elevated, as measured by the HyPer-Cyto
biosensor (Wu et al., 2010) (Figure 2F). These data implied an
essential role of KIF12 in the antioxidant capacity of beta cells
by helping the peroxisomal import.
KIF12 Scaffolds the Sp1 Transcription Factor for Hsc70
Gene Expression
We further identified a significant downregulation of the Hsc70
chaperone protein by KIF12 deficiency, as an upstream mecha-
nism underlying the impaired peroxisomal targeting, using
immunofluorescence microscopy in KO cells and immunoblot-
ting in KD cells (Figure 3). This Hsc70 downregulation was fully
rescued by full-length KIF12, but not by motorless (ML) KIF12,
in both KO and KD cells, suggesting that a microtubule-related
function of this motor is essential for proper Hsc70 expression
(Figures 3B–3E).
To compare the Hsc70 turnover rate, we transduced primary
beta cells with photoactivatable green fluorescent protein
(PAGFP)-tagged Hsc70 and chased the fluorescent signal decayd glucose (H) and plasma insulin levels (I). n = 5. **p < 0.01 by two-way ANOVA
ations of glucose. n = 6. *p < 0.05; NS, p > 0.05 by Welch’s t test.
y ANOVA. Data are mean ± SEM throughout this figure.
ier Inc.
D(KO)(WT) 80
0
40
*
20
60
F
**
WTKO
80
0
40
Ca
ta
la
se
Ac
tiv
i ty
 
(a.
u
.)
2O
2 
Le
ve
l (a
.u.
)H2O2
High
WT KO
0
20
40
60
A
**
SC KD
0
10
20
30
40
PT
S1
 L
ev
el
(a.
u.)
 **
PTS1
Impaired Peroxisome Import
(SC)
(KD)
(WT)
(KO)
PT
S2
 L
ev
el
(a.
u.)
 
BPTS2
*
WTKO
120
0
60
G
Px
Ac
tiv
ity
 (a
.
u
.
)E
(SC)
(KD)
SC KD
0
10
20
30
40 **
PT
S2
 L
ev
el
(a.
u.)
 
Oxidative Stress Elevation
60
anti-Pex5
 (80 kD)
SC KD KD
+K
IF1
2
0
120
Pr
o
te
in
 L
ev
el
(%
)
****
SC KD
KD
+K
IF1
2
C
Figure 2. KIF12 Deficiency Results in Peroxisome Dysfunction and
Increased Oxidative Stress
(A and B) Impaired peroxisomal targeting due to KIF12 deficiency, represented
by PTS2 immunofluorescence using an anti-ACAA1 antibody in WT and KO
islet cells (n = 5–7; A, left panel) and in MIN6 cells transduced with SC and KD
miRNA vectors (n = 6; A, right panel); and fluorescence micrographs of ECFP-
PTS1-expressingMIN6 cells transducedwith SC (n = 9) and KD (n = 12)miRNA
vectors (B) and corresponding quantification. **p < 0.01 byWelch’s t test. a.u.,
arbitrary units.
(C) Immunoblotting against Pex5 of the KIF12-KD rescue system in MIN6 cells
and corresponding quantification. n = 6; **p < 0.01 by Welch’s t test.
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Developmfor 6 hr after photoactivation in each cell. As a consequence, the
turnover rate of PAGFP-Hsc70 protein was not significantly
altered (Figure 3F), suggesting that Hsc70 protein stability was
unlikely to be the cause of its downregulation in KIF12 deficient
beta cells.
We then analyzed the transcriptional status of the Hsc70 gene
in KIF12-deficient beta cells. First, a consistent decrease in
Hsc70mRNAwith KIF12 deficiency was revealed by quantitative
RT-PCR (qRT-PCR) in KO islets (in vivo) and MIN6 cells trans-
duced with the KD miRNA vector (in vitro; Figure 4A). Chasing
after treatment with the transcriptional inhibitor actinomycin D
in both the in vivo and in vitro systems indicated that the turnover
rate of Hsc70 mRNA did not significantly change due to KIF12
deficiency (Figure 4B). We then carried out Hsc70 promoter re-
porter assays using the dual fluorescent reporter construct
p70-R/G, which also contains an internal control for transfection
(Figure 4C). The results showed that Hsc70 promoter activity in
KIF12 KO islet cells was lower than that in WT cells, suggesting
that KIF12 is involved in Hsc70 transcriptional regulation.
We compared the levels of several transcriptional factors
enhancing the Hsc70 gene by immunoblotting, which finally re-
vealed a specific and significant downregulation of Sp1 protein
in KIF12-deficient cells to approximately 70% of control levels
(Figure 4D). This result was further confirmed by a specific chro-
matin immunoprecipitation (ChIP) assay in the MIN6 knockdown
system, which showed a reduced binding of Sp1 protein to the
Hsc70 promoter region (Figure 4E). This Sp1 downregulation
was considered to bemainly due to an acceleration of the protein
degradation rate, as evidenced by a protein degradation assay
chased in the presence of the protein synthesis inhibitor cyclo-
heximide (CHX) for 4 hr (Figures 4F–4H). Immunoblotting against
Sp1 over this time course revealed that the turnover rate of Sp1
was significantly accelerated in the knockdown cells and that the
lower of the two Sp1 bands, which is considered to represent a
nascent cytoplasmic form of Sp1 (Rippe et al., 1995), was partic-
ularly sensitive to degradation.
KIF12 Assists in Sp1 Scaffolding Complex Association
on Microtubules
To understand the mechanism underlying KIF12-mediated Sp1
stabilization, we conducted intrinsic and tagged immunoprecipi-
tation (IP) studies usingMIN6cell lysates. Through thesemethods,
a significant association among KIF12, Sp1, and Hsc70 was de-
tected (Figures 4I–4L). Intriguingly, both Hsc70 and KIF12 bound
preferentially to the lower band of Sp1 (Figures 4I and 4K), sug-
gesting that thenascent formofSp1 isstabilizedby theseproteins.
To understand the morphological features of this scaffolding
complex, we examined mCitrine-KIF12-transduced and immu-
nostained primary KO islet cells using triple-color photoacti-
vated localization microscopy/stochastic optical reconstruction(D and E) Antioxidant enzyme activities of catalase (D; n = 7) and GPx (E; n =
4–5) in WT and KO islets. *p < 0.05; **p < 0.01 by Welch’s t test.
(F) Intracellular H2O2 levels in WT (n = 13) and KO (n = 16) primary islet cells
measured by ratiometry of the HyPer-Cyto fluorescence and corresponding
quantification. Pseudo-grayscale intensity: white > black. *p < 0.05 byWelch’s
t test.
Scale bars in all images, 5 mm. Data are mean ± SEM throughout this figure.
See also Figure S2.
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Figure 3. KIF12 Augments Expression of the
Antioxidant Chaperone Hsc70
(A) Hsc70 immunofluorescence in primary WT and
KO islet cells (n = 12) and corresponding quantifi-
cation. **p < 0.01 by Welch’s t test. a.u., arbitrary
units.
(B) Schematic representation of the mCitrine-tag-
ged KIF12 expression vectors used in the rescue
experiments. Yellowoval,mCitrine fluorescent tag.
(C) Hsc70 immunofluorescence in KO cells
rescued with the indicated expression vectors
(n = 6) and corresponding quantification. **p <
0.01; NS, p > 0.05 by Welch’s t test.
(D and E) Immunoblotting of KIF12 KD MIN6 cells
rescued with RNAi-immune full-length (D) and ML
(E) rescue constructs labeled using anti-KIF12
(12T), anti-Hsc70, and anti-a-tubulin antibodies
and corresponding quantification. Closed and
open arrowheads in (D) refer to mCitrine-tagged
and intrinsic KIF12 proteins, respectively. n = 6.
**p < 0.01; NS, p > 0.05 by Welch’s t test.
(F) Hsc70 protein degradation assay in primary
islet cells of the indicated genotypes transduced
with a photoactivatable-GFP-tagged Hsc70
(PAGFP-Hsc70). WT, n = 10; KO, n = 13. NS, p >
0.05 by two-way ANOVA.
Scale bars in all images, 5 mm. Data are mean ±
SEM throughout this figure.
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simultaneously visualized Sp1/KIF12/a-tubulin (Figures 5A–5E)
and Sp1/KIF12/Hsc70 (Figures 5F–5J). Microtubules were de-
picted as filamentous structures (Figure 5E) on which tubulove-
sicular Sp1 (Figures 5C and 5H), mCitrine-KIF12 (Figures 5D
and 5I), and Hsc70 (Figure 5J) signals appeared to be partially
colocalized (Figures 5B and 5G). These data implied that Sp1
binds to KIF12 and Hsc70 on microtubules to be stabilized.
Next, we assessed the relevance of KIF12 to the tendency of
Sp1 to colocalize with Hsc70. First, we double-stained WT and206 Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsevier Inc.KO cells using specific Sp1 and Hsc70
antibodies (Figures 5K–5P) and quantified
the colocalization index as the number of
double-stained spots over the total num-
ber of Sp1-labeled spots (see camera
lucida in Figure 5N). Statistical analysis
revealed a significant downregulation of
the colocalization index in KO cells to
almost the half of that in WT cells (Fig-
ure 5P). Because the decrease in the
colocalization index tended to be more
severe than the rate of Hsc70 downregu-
lation (Figures 3A and 3D), the presence
of KIF12 in this complex was considered
to largely enhance the synergy of the sta-
bilization complex.
In addition, the relevance of the KIF12
motor domain was assessed in rescue
experiments. We compared the colocali-
zation index in cells rescued with a full-
length KIF12 construct (12FL) or ML
KIF12 construct (12ML) (Figures 5Q–5V).These experiments demonstrated that 12FL, but not 12ML,
could significantly restore the colocalization index (Figure 5V),
suggesting that the KIF12 motor domain is indispensable for
enhancing the Sp1-Hsc70 interaction.
FA-Induced Lipotoxicity Follows the KIF12 Deficiency
Pathway in Beta Cells
To determine the involvement of KIF12 in the pathogenesis of
diabetes, we investigated the possible change in KIF12 expres-
sion through HNF1a inactivation on chronic FA treatment (Luco
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Figure 4. KIF12 Associates with and Stabilizes the Sp1 Transcription Factor, Enhancing Hsc70/Hspa8 Gene Expression
(A) qRT-PCR analyses of Hsc70 mRNA levels in islets recovered from WT and KO mice (in vivo, n = 3) and in MIN6 cells transduced with SC and KD miRNAs
(in vitro, n = 6) normalized to b-actin levels. *p < 0.05; **p < 0.01 by Welch’s t test.
(legend continued on next page)
Developmental Cell
KIF12 Regulates Oxidative Stress in Beta Cells
Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsevier Inc. 207
Developmental Cell
KIF12 Regulates Oxidative Stress in Beta Cellset al., 2008; Ohtsubo et al., 2011) (Figure 6A). Our qRT-PCR
assay revealed that Kif12 and downstream Hsc70 mRNA levels
in the pancreatic islets of WT mice fed with an HFD were signif-
icantly downregulated to 5% and 70%, respectively, of levels in
mice fed with a normal-fat diet after 2 weeks (Figure 6B). These
in vivo results were reproduced using an in vitroMIN6 cell system
with FA treatment (0.5 mM palmitic acid) for 48 hr (Figure 6C).
This system was then subjected to a ChIP assay using a specific
anti-HNF1a antibody to coprecipitate the Kif12 gene promoter
region, which indeed revealed a significant decrease in the asso-
ciation with the FA treatment (Figure 6D). These results support
our working hypothesis regarding lipid-induced Kif12 gene regu-
lation (Figure 6A).
We then investigated how well our KIF12-KO beta cells phe-
nocopied beta cell lipotoxicity by comparing the phenotypes of
FA-treated and KIF12-deficient beta cells. Based on immuno-
blotting, the expression levels of KIF12, Sp1, and Hsc70 protein
in FA-treated cell lysates were significantly reduced to approxi-
mately half the levels in control cultures, although the levels of
the internal control a-tubulin levels were unaltered (Figure 6E).
This downregulation was consistent with the data in KD cells
(Figures 3D and 4D). Furthermore, oxidative stress was signifi-
cantly elevated (Figure 6F), and peroxisomal targeting of the
PTS2 marker was significantly reduced (Figure 6H), consistent
with the respective data in KO cells (Figures 2F and 2A, respec-
tively). These data proposed that FA treatment of beta cells
induced KIF12 downregulation, which resulted in increased
oxidative stress according to the aforementioned molecular
cascade induced by KIF12 deficiency, suggesting that our
KIF12-KO mice can serve as a model for beta cell lipotoxicity.
This genetic model is considered more organ specific than the
HFD-fed mouse model, to eliminate the peripheral insulin resis-
tance due to obesity.
To test the capability of KIF12 to counteract beta cell lipotox-
icity, we examined whether the overexpression of KIF12 could
overcome the FA-induced peroxisomal defects. We treated
WT islet cells with FA for 2 days after transduction with
mCitrine-Kif12 cDNA or fluorescent protein only (mock) driven
by a CMV promoter. mCitrine-Kif12 transduction resulted in a
significant restoration of KIF12 protein expression levels by(B) Hsc70 mRNA degradation assay in WT and KIF12-KO islets (in vivo) or in M
treatment with 5 mg/ml actinomycin D. qRT-PCR results are shown as the perce
(C) Hsc70 promoter reporter assay in primary islet cells transfected with p70-R/
protein (RFP)/GFP channel fluorescence (middle panel) and corresponding quan
n = 10; **p < 0.01 by Welch’s t test.
(D) Immunoblotting in lysates from the KIF12-KD system in MIN6 cells probed wit
NS, p > 0.05 by Welch’s t test.
(E) ChIP-qPCR assay of the KIF12-KD system in MIN6 cells using an anti-Sp1 ant
Welch’s t test.
(F–H) Sp1 degradation assay in the KIF12-KD system in MIN6 cells by immunoblo
(G) and upper and lower Sp1 bands (closed and open arrowheads, respectively; H
by two-way ANOVA.
(I–L) IP of KIF12, Sp1, and Hsc70. (I) Tag-IP of mCitrine-KIF12- or mCitrine-expre
anti-KIF12 (12T), anti-Hsc70, and anti-Sp1 antibodies. Closed and open arrowhe
figures. Note that the lower Sp1 band was specifically coprecipitated with mCitri
normal rabbit IgG (NRG) and immunoblotted (IB) with anti-Sp1 and anti-KIF12 anti
MIN6 cell lysates immunoblotted with anti-GFP and anti-KIF12 antibodies. Note
(L) Intrinsic IP from MIN6 cell lysates using a rabbit anti-KIF12 antibody (12T), NR
and immunoblotted (IB) with anti-KIF12 (12T) and anti-Hsc70 antibodies.
Data are mean ± SEM throughout this figure.
208 Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsevimmunoblotting (Figure 6G) and restored PTS2 expression in
peroxisomes by immunofluorescence microscopy compared
with mock cDNA transfection (Figure 6H). These data suggest
that the forced overexpression of KIF12 may restore peroxisome
biogenesis in FA-treated beta cells.
Induction of Hsc70 by Teprenone Can Counteract KIF12
Deficiency in Beta Cells
We further investigated the ability of Hsc70 to counteract
beta cell lipotoxicity in a similar manner. We generated a
pCMV-driven ECFP-Hsc70 expression vector and character-
ized it by immunoblotting (Figure S3). In the first place, we
transduced WT islet cells with this cDNA (or mock transduction)
and treated the cells with FA for 2 days. In the second
place, we transduced KO islet cells with these constructs. In
both cases, the overexpression of Hsc70 cDNA significantly
restored peroxisomal PTS2 immunofluorescence compared
with levels following mock transfections (Figures 6I and 6J).
These data suggest that Hsc70 overexpression could success-
fully restore peroxisomal biogenesis in cellular models of
lipotoxicity.
To test the potential for chaperone induction in higher order
systems, we then performed pharmacological treatment with
teprenone in the KIF12- KOmousemodel. First, teprenone treat-
ment of primary islet cells in vitro or the systemic administration
in KOmice in vivo significantly induced Hsc70 expression in islet
cells, as detected by immunofluorescence and immunoblotting
(Figures 7A and 7B). Teprenone also reduced the H2O2 levels
by HyPerCyto-mediated fluorescence ratiometry in primary
cultured KO islet cells by administration in vitro (Figure 7C) and
in vivo (Figure S4), and those in FA-treated WT islet cells admin-
istered in vitro (Figure 7D). In the teprenone-treated KO mice,
the GSIS rate of islets was significantly improved to almost
twice of that in untreated KOmice (Figure 7E), and glucose intol-
erance by the intraperitoneal glucose tolerance test (IPGTT) was
significantly ameliorated (Figure 7F). These data collectively
suggest that teprenone administration can profoundly reverse
the diabetic phenotype in the KIF12-deficient lipotoxicity
mouse model, thereby providing experimental evidence for the
relevance of the Hsc70 chaperone and KIF12 kinesin in anIN6 cells transduced with SC and KD miRNA vectors (in vitro) chased after
ntage of the amounts at 0 hr. n = 3. NS, p > 0.05 by two-way ANOVA.
G reporter vector (left panel). Data are shown as ratiometry of red fluorescent
tification (right panel). SPA, synthetic polyadenylation signal. WT, n = 15; KO,
h the indicated antibodies and corresponding quantifications. n = 6. **p < 0.01;
ibody to quantify the coprecipitated Hsc70 promoter region. n = 6. *p < 0.05 by
tting at the indicated times after CHX treatment (F). The intensities of total Sp1
) were quantified after normalization using the values at 0 hr (h). n = 3. **p < 0.01
ssing MIN6 cell lysates against GFP (mCitrine) immunoblotted with anti-GFP,
ads indicate the upper and lower bands of Sp1, respectively, throughout the
ne-KIF12. (J) Intrinsic IP from MIN6 cell lysates with an anti-Sp1 antibody and
bodies. (K) Tag-IP against GFP (ECFP) from ECFP-Hsc70- or ECFP-expressing
that the lower Sp1 band was specifically coprecipitated with ECFP-Hsc70.
G, a mouse anti-Hsc70 antibody, and normal mouse immunoglobulin G (NMG)
ier Inc.
Figure 5. Visualization of the Sp1 Scaffolding Complex Involving KIF12
(A–J) PALM/STORM of mCitrine-KIF12-expressing KO primary beta cells at low (A and F) and high (B–E; G–J) magnifications; merged images (A, B, F, and G),
anti-Sp1 immunofluorescence (C and H; red in the merged images), mCitrine-KIF12 fluorescence (D and I; green), anti-a-tubulin immunofluorescence (E, blue),
and anti-Hsc70 immunofluorescence (J, blue) are presented. Circles, triple-colocalizing spots.
(legend continued on next page)
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KIF12 Regulates Oxidative Stress in Beta Cellsantioxidant cascade that serves as an essential target in beta cell
lipotoxicity (Figure 7G).
DISCUSSION
In this study, we have identified a role for KIF12 kinesin as the
cytoplasmic scaffold that promotes the stability of a transcrip-
tional factor. This mechanism may provide a critical step in the
beta cell antioxidant pathway, which is an essential target for
beta cell lipotoxicity through the transcriptional downregulation
of KIF12. These findings will support the development of antiox-
idant therapies against beta cell lipotoxicity in diabetes using
KIF12-KO mice as a specific genetic model.
In our efforts to understand the nature of KIF12 as a cyto-
plasmic scaffold for the Sp1 transcription factor, our protein-
protein interaction study using IP (Figures 4I–4L) and superreso-
lutionmicroscopy (Figure 5) revealed that KIF12, Hsc70, and Sp1
form a tertiary complex on microtubules, which may stabilize the
nascent Sp1 protein. The loss of KIF12 significantly reduced the
Hsc70-Sp1 colocalization index (Figures 5K–5V) and the stability
of the nascent Sp1 protein (Figures 4F–4H), reducing cellular Sp1
protein levels (Figure 4D) and mimicking FA-treated beta cells
(Figure 6E). Both the Hsc70-Sp1 interaction and the presence
of Hsc70 have been reported to be indispensable for Sp1 stabil-
ity, which is negatively regulated by GLIPR1 in prostate cancer
cells (Li et al., 2013). Because Hsc70 function is highly dynami-
cally modulated by its associated proteins (Ho¨hfeld et al.,
1995; Meacham et al., 2001; Tzankov et al., 2008), our findings
suggest that KIF12 is an Hsc70 binding partner that helps it to
stabilize the nascent Sp1 protein. Hsc70 was initially identified
as a microtubule-associated protein called b-internexin (Green
and Liem, 1989) and has been reported to bind to kinesin-1 (Ter-
ada et al., 2010; Tsai et al., 2000). Polyribosomes are associated
with microtubules as well (Hamill et al., 1994). Thus, KIF12 may
translocate along microtubules using its plus-end-directed
motor activity and pick up the Hsc70 protein and the newly trans-
lated Sp1 protein from the polyribosomes stepwise to build the
tertiary Sp1-KIF12-Hsc70 protein complex on the microtubules,
which we visualized using superresolution microscopy. This
concept of a kinesin motor as a unique protein-stabilizing scaf-
fold might be generally applied to additional kinesins toward
the further elucidation of the mechanisms underlying howmicro-
tubules modulate the stability of proteins involved in various
signaling pathways (Ziegelbauer et al., 2001).
This complex formation is suggested to augment Sp1-medi-
ated Hsc70 transcription (Figure 4). The Hsc70 protein is consid-
ered to be essential for an antioxidant pathway in pancreatic
beta cells (Figures 2, 4, 6, and 7), consistent with the antioxidant
capacity of Hsc70 in esophageal cancer cells (Wang et al., 2013)
and with that of Sp1 in neurons (Ryu et al., 2003), lung fibroblasts
(Zelko et al., 2008), and lenses (Chhunchha et al., 2011). In the(K–V) Comparison of Hsc70-Sp1 association by PALM/STORMof nontransfected
KO primary beta cells transduced with the mCitrine-KIF12ML construct (KO+12M
lower panel) at low (K and Q) and high (L–O and R–U) magnification. Images depict
signals in spots that do not (rose) or do colocalize (white, circled) with Hsc70 (
corresponding quantification of the colocalization index (P and V). Closed and ope
columns indicate the total number of spots identified in the indicated entity. **p <
Scale bars in this figure, 2 mm.
210 Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsevcase of beta cells, peroxisome biogenesis is considered one of
the most crucial antioxidant properties of Hsc70, because beta
cell peroxisomes are highly vulnerable to oxidative stress due
to the naturally low expression levels of antioxidant enzymes
that largely function in the peroxisomal matrix (Lenzen et al.,
1996). We observed an impaired peroxisomal targeting of matrix
proteins in KIF12-deficient or FA-treated beta cells. The levels of
these proteins in the cytosol tended to remain low in KO cells
(Figure 2), which may be partly because the mistargeted
proteins were degraded through the ER-associated degradation
process (Schlu¨ter et al., 2006). Teprenone treatment or the
transduction of an ECFP-Hsc70 expression vector very nicely
induced Hsc70 expression and peroxisome biogenesis and
eliminated oxidative stress in KIF12- KO or FA-treated beta cells
(Figures 6 and 7). Thus, our working hypothesis of beta cell
lipotoxicity, in which chronic FA exposure destroys KIF12-medi-
ated peroxisomal biogenesis resulting in beta cell dysfunction
(Figure 7G), will be useful in explaining this particular step in dia-
betes progression, in which excessive nutritional intake irrevers-
ibly harms the body’s metabolic homeostasis. This signaling
function of KIF12 will also be crucial for understanding pancre-
atic islet development and regeneration, which warrant future
research.
EXPERIMENTAL PROCEDURES
cDNA Cloning and Immunochemical Procedures
Full-length Kif12 cDNA (2,287 base pairs) was cloned and sequenced from an
ICR mouse kidney library. Specific anti-mouse-KIF12 polyclonal antibodies
were raised by immunizing rabbits with the synthetic peptides HMPQVLEPEA
PGHISQSVWC (12PR) or AGPSNMPYGLRGGSGIPNLTPRLETLTQC (12T)
(Sigma) and were affinity purified as described elsewhere (Zhou et al., 2009).
Immunoblotting and IP assays were performed as described elsewhere (Yin
et al., 2011; Zhou et al., 2009). For Sp1 protein degradation assays,
10 mg/ml CHX was administered into the medium and chased for the indicated
periods of time.
Mice
KIF12 KO mice were generated as described elsewhere (Tanaka et al., 1998)
and maintained in a specific pathogen-free environment at the University of
Tokyo in accordance with institutional guidelines. IPGTT and IPITT were per-
formed as described elsewhere (Strader et al., 2004; Wang et al., 2012). WT
mice were fed an HFD (#HFD32, CLEA Japan) for 2 weeks. Teprenone
(Wako) was administered intraperitoneally at 200 mg/kg body weight as an
emulsion in saline once daily for 2 weeks (Ishii et al., 2003).
Islets and Cells
Mouse pancreatic islets were collected as described elsewhere (Szot et al.,
2007), followed by overnight recovery (Carter et al., 2009) for use in GSIS
(Cantley et al., 2009), enzyme activity assays (Johansson and Borg, 1988),
and primary cultures (Bosco et al., 2000; Carter et al., 2009; Guillam et al.,
2000). MIN6 cells (Miyazaki et al., 1990) were stably transfected with
pECFP-SKL vector for the PTS1 assay or transduced with adenoviral vectors
for the KD-rescue system using RNA-polymerase-II-mediated RNA interfer-
ence (Invitrogen) and those for protein overexpression experiments. For theWT (K–O, upper panel) and KO (K–O, lower panel) primary beta cells and that of
L; Q–U, upper panel) andmCitrine-KIF12 full-length construct (KO+12FL; Q–U,
anti-Sp1 immunofluorescence (M and S; rose in L and R), camera lucida of Sp1
N and T), anti-Hsc70 immunofluorescence (O and U; green in L and R), and
n bars, Sp1 spots without andwith Hsc70 signals, respectively. Numbers within
0.01 by chi-square test.
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Figure 6. Excess FA Intake Downregulates KIF12 and Hsc70 in Beta Cells
(A) Working hypothesis of transcriptional downregulation of the Kif12 gene in beta cells mediated by HFD intake.
(B and C) FA-induced transcriptional downregulation of Kif12 andHsc70mRNA levels by qRT-PCR analyses in islets recovered frommice fed HFD or not (in vivo;
B) and in MIN6 cells treated with FA or not (in vitro; C). n = 3–6. *p < 0.05 by Welch’s t test. a.u., arbitrary units.
(D) ChIP-qPCR assay of MIN6 cells treated with FA or not using a goat anti-HNF1a antibody and normal goat immunoglobulin G (NGG) to quantify the copre-
cipitated Kif12 promoter region. n = 3. *p < 0.05 by Welch’s t test.
(E) Immunoblotting of MIN6 cell lysates treated with FA or not using antibodies against KIF12, Sp1, Hsc70 and a-tubulin and corresponding quantification. n = 3.
*p < 0.05; **p < 0.01; NS, p > 0.05 by Welch’s t test.
(F) Ratiometric analyses of intracellular H2O2 levels in WT islet cells with or without FA treatment and corresponding quantification. n = 8–10. Pseudo-grayscale
intensity: white > black. **p < 0.01 by Welch’s t test.
(G) Immunoblottingwith antibodies against KIF12 and a-tubulin in FA-treatedMIN6 cell lysateswith or without transduction with themCitrine-KIF12 construct and
corresponding quantification. n = 6. **p < 0.01; NS, p > 0.05 by Welch’s t test.
(H–J) Immunofluorescence micrographs after staining with an antibody against the intrinsic PTS2 marker ACAA1 in FA-treated WT islet cells (FA), carrier-treated
WT islet cells (mock), and FA-treated WT islet cells with mCitrine-KIF12 overexpression (FA+KIF12) (H); in FA-treated WT islet cells with ECFP (FA+mock) or
ECFP-Hsc70 (FA+Hsc70) overexpression (I); and in KO islet cells with ECFP (KO+mock) or ECFP-Hsc70 (KO+Hsc70) overexpression (J); and corresponding
quantification. n = 10–13. *p < 0.05; **p < 0.01 by Welch’s t test.
Scale bars in all panels, 5 mm. Data are mean ± SEM throughout this figure. See also Figure S3.
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(w/v) BSA with or without 0.5 mM palmitic acid for 48 hr (Ohtsubo et al., 2011)
and 20 mM teprenone for 24 hr, respectively.DevelopmFluorescence Microscopy
Immunofluorescencemicroscopy was performed as described elsewhere (Yin
et al., 2011), using an LSM-5Duo or LSM-710 confocal laser-scanningental Cell 31, 202–214, October 27, 2014 ª2014 Elsevier Inc. 211
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Figure 7. Teprenone Counteracts KIF12 Deficiency in Beta Cells
(A and B) Hsc70 induction by teprenone in KO islet cells, represented by
immunofluorescencemicrographs of KO islet cells treated for 24 hr with 20 mM
teprenone (KO+Tep) or not (KO) in vitro (A, n = 10), and by immunoblotting of
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212 Developmental Cell 31, 202–214, October 27, 2014 ª2014 Elsevmicroscope or an ELYRA P.1 superresolution microscope (ZEISS). For the
H2O2 assays, cells were adenovirally transduced with the pHyPer-Cyto vector
(Evrogen) for 24 hr for ratiometry of emission signals at 405 and 488 nm exci-
tations (Berg et al., 2009). For the Hsc70 degradation assay, cells were adeno-
virally transduced with the pPAGFP-Hsc70 vector, photoactivated with a
405 nm laser, and chased for the indicated periods of time (Yin et al., 2011).
Gene Regulation
mRNA levels and stability were assayed using SYBR-green-mediated qRT-
PCR as described elsewhere (Livak and Schmittgen, 2001), following treat-
ment with 5 mg/ml actinomycin D (Wako). Hsc70 promoter activity in primary
islet cells was assessed by transfection of cells with the dual fluorescent
reporter construct p70-R/G using Lipofectamine LTX with PLUS Reagent
(Invitrogen) and observation by confocal microscopy. Enhancer binding activ-
ity was assayed using the ChIP-quantitative real-time PCR (ChIP-qPCR) assay
as described elsewhere (Nelson et al., 2006; Pa´rrizas et al., 2001).
Data Analyses
All experiments were performed multiple times. All primary culture studies
were repeated using cells from different animals. The images were quantified
using ImageJ software (Schneider et al., 2012). All of the data are presented as
the means ± SEM. Statistical analyses were performed using the two-way
ANOVA, Welch’s t test, or chi-square test as indicated. Detailed procedures
are described in the Supplemental Experimental Procedures.
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